Hope’s d-Nav Journey

d-Nav Patient Hope with her nurse Kelly

Hope has been using d-Nav consistently for nearly a year. She credits a new-found therapy adherence to d-Nav’s ease of use and provider support.

Read More

Autonomous Insulin Dose Adjustments: A Game-Changer in Type 2 Diabetes Care

Diabetes affects more than 37 million people in the U.S. and increases their risk of early death by 60%.1 Numerous clinical studies show that the maintenance of glycated hemoglobin (HbA1c) at about 7% prevents complications, slows the disease progression, and prevents premature death. Despite advances in pharmacotherapy, most patients with long-standing type 2 diabetes progress…

Read More

What HbA1c level do I need to aim for?

If you have diabetes, you have most likely heard that you should aim for an HbA1c measure of 7 percent or lower. But what does this really mean? HbA1c is a measure of average glucose over a period of about 2-3 months. It essentially evaluates how much glucose binds to your hemoglobin. Since red blood…

Read More

Insulin’s Next Century: Technology’s role in unlocking the power of insulin

One hundred years ago a group of Canadian scientists and physicians discovered insulin. Frederick Banting, J.R. Macleod, Charles Best and James Collip’s historic finding meant the difference between life and death for people with diabetes.  Nearly a century later, Hygieia co-founder Dr. Israel Hodish published a paper1 in Clinical Diabetes and Endocrinology asking the question,…

Read More

Diabetes discriminates: Why one’s ethnicity can impact the likelihood of developing type 2 diabetes and suffering from its complications

Type 2 diabetes affects about 10% of the general population in the United States. Yet, it occurs in nearly 15% of the Native-American population, nearly 12% of the non-Hispanic black population, and nearly 13% of the Hispanic population, according to the American Diabetes Association. Why does type 2 diabetes impact some ethnicities and races more…

Read More

Insulin Therapy: The How and Why of Dose Changes

Most patients who use insulin therapy use it for type 2 diabetes. Type 2 diabetes is a progressive condition of insulin deficiency, which means that over time the body secretes less and less insulin. During the second decade of the disease, most patients require insulin injections because they become overtly insulin deficient and no longer…

Read More

Diabetes and heart disease: How to manage the risk

Although diabetes is a condition of the endocrine system, it also can affect many other systems in the body. For example, there is a strong link between diabetes and cardiovascular disease.  In fact, cardiovascular disease is the most prevalent cause of death (mortality) and complications (morbidity) in diabetic populations. Cardiovascular death rates in the United…

Read More

Artificial Intelligence: Just what the doctor ordered

Medicine is the next industry where AI will replicate human decision making Just as the 2008 recession ushered in an era of unbridled innovation in financial tech, the effects of the COVID-19 pandemic are similarly accelerating a radical shift in medicine. In the last year, as COVID-19 overwhelmed hospitals and physicians struggled to deliver care…

Read More

Insulin Therapy and the Weight Paradox

Most patients with adult-onset diabetes or type 2 diabetes will require insulin therapy at some point. Typically, it happens toward the second decade of the disease. In many cases, patients gain weight during the first six to 12 months after they start insulin therapy. On average, people gain about 10 pounds.  Interestingly, insulin therapy does…

Read More